✦
UWELL CLOUD YOU JIAN YUN

LK101 Patient Journey: Preparation, Timing and Travel Questions

Exterior of Ruijin Hospital Hainan Branch · Stylized calendar illustration

Planning an LK101 enquiry involves clinical information, possible sample preparation and practical coordination. This guide separates preparation estimates from confirmed appointments so you can discuss the next steps before committing to travel.

Start with clinical and sample review

Prepare pathology reports, recent imaging, treatment and medication history, and available tumor-sample information for the clinical team. Obtain current collection and transport instructions from the hospital before arranging any sample shipment.

Understand the preparation timeline

The manual estimates about six weeks for sequencing, antigen prediction and mRNA preparation, followed by about three weeks for vaccine preparation after white-cell collection. These are indicative preparation periods, actual treatment and travel scheduling must be confirmed.

The supplied manual describes a sequence of clinical assessment, tumor-sample review, sequencing and personalized preparation, white-cell collection and vaccine preparation, followed by treatment and follow-up. Ask which steps apply to your situation, where they take place, and what must be confirmed before arranging flights or accommodation. Preparation periods are not appointment dates.

Explore LK101 and request coordination support

Confirm the hospital and access pathway

The supplied technical manual names West China Lecheng Hospital of Sichuan University (四川大学华西乐城医院), Hainan, as the treatment hospital. The team must confirm current access, eligibility and appointments for each enquiry.

The materials refer to clinical-trial clearance and a Lecheng translational-application pathway. Permission to conduct research and a local access pathway should not be described as general drug marketing approval. Ask the hospital which pathway applies to the proposed care.

Choose the coordination support you need

Uwell helps coordinate enquiries and medical-record preparation. Eligibility and treatment decisions remain with the clinical team. Medical fees are quoted and collected directly by the provider; Uwell does not collect medical fees.

Sources and scope

Based on the supplied Likang introduction, technical manual and brochure. Manufacturer information is attributed and current access needs confirmation. These sources do not replace an individual clinical assessment.

Likang slides PDF 2–5, 7–20; technical manual printed pages 11–14.

ClinicalTrials.gov · NCT06054932

This article was produced with AI assistance and reviewed against Uwell Cloud editorial and compliance standards.

Important medical & regulatory notice. This page is for general information only and is not medical advice, a diagnosis, a prescription, or a guarantee of any outcome. Treatment availability and eligibility for any individual are determined solely by clinical review at the treating hospital. Uwell Cloud is an international medical-travel coordinator, not the treating provider.
Explore LK101 and request coordination support
← All insights